EVI1 upregulation is detected in approximately 8%–10% of MDS/AML and 30% of advanced CML; however, the mechanism that results in EVI1 overexpression remains unclear (16). Here, MECOM is linked to chronic myelogenous leukemia, BCR-ABL1 positive.